Antineoplaston Therapy in Treating Patients With Ependymoma

NCT00003479 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Ependymoma

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute